Neuroendocrine tumors of the pancreas: etio-pathogenesis, diagnosis, current treatment
https://doi.org/10.16931/1995-5464.20182100-110
Abstract
Review is devoted to current problems of classification, diagnosis and treatment of pancreatic neuroendocrine tumors. According to modern views, all pancreatic neuroendocrine tumors over 5 mm or those followed by clinical manifestations are biologically malignant. It is shown that certain proportion of pancreatic neuroendocrine tumors are non-functioning. Diagnosis of neuroendocrine tumors is highly difficult issue. Currently, surgery is only radical and adequate approach for functioning pancreatic tumors. Need to optimize diagnostic and surgical algorithm for improvement of outcomes in these patients is emphasized.
About the Authors
N. Yu. Kokhanenko
St. Petersburg State Pediatric Medical University of Healthcare Ministry of the Russian Federation
Russian Federation
Doct. of Med. Sci., Professor, Head of the Rusanov Chair of Faculty-Based Surgery of SaintPetersburg State Pediatric Medical University of Healthсare Ministry of Russia
Russian Federation
Doct. of Med. Sci., Professor, Head of the Rusanov Chair of Faculty-Based Surgery of SaintPetersburg State Pediatric Medical University of Healthсare Ministry of Russia
T. Sh. Morgoshiya
St. Petersburg State Pediatric Medical University of Healthcare Ministry of the Russian Federation
Russian Federation
Cand. of Med. Sci., Associate of the Rusanov Chair of Faculty-Based Surgery of Saint-Petersburg State Pediatric Medical University of Healthсare Ministry of Russia
Russian Federation
Cand. of Med. Sci., Associate of the Rusanov Chair of Faculty-Based Surgery of Saint-Petersburg State Pediatric Medical University of Healthсare Ministry of Russia
References
1. Modlin I.M., Lye K.D., Kidd M.A. 5-decade analysis of 13,715 carcinoid tumors. Cancer. 2003; 97 (2): 934–959. DOI: 10.1016/S0140-6736(05)63453-8.
2. Ohmoto A., Rokutan H., Yachida S. Pancreatic neuroendocrine neoplasms: basic biology, current treatment strategies and prospects for the future. Int. J. Mol. Sci. 2017; 18 (1): 143. DOI: 10.3390/ijms18010143.
3. Reid M.D., Balci S., Saka B., Adsay N.V. Neuroendocrine tumors of the pancreas: current concepts and controversies. Endocr. Pathol. 2014; 25 (1): 65–79. DOI: 10.1159/000098006.
4. Delektorskaya V.V. Neuroendocrine pancreatic tumors: new aspects of morphological classification (World Health Organization, 2017). Uspekhi molekulyarnoj onkologii. 2017; 4 (3): 104–108. (In Russian)
5. Gorbunova V.A., Orel N.F., Egorov G.N., Kuz'minov A.E. Vysokodifferencirovannye nejroehndokrinnye opuholi (karcinoidy) i nejroehndokrinnye opuholi podzheludochnoj zhelezy [Highly differentiated neuroendocrine tumors (carcinoids) and neuroendocrine pancreatic tumors]. Moscow: Litera, 2007. 104 p. (In Russian)
6. Imyanitov E.N. Epidemiology and biology of neuroendocrine tumors. Prakticheskaya onkologiya. 2005; 6 (4): 202–205. (In Russian)
7. Fraenkel M., Kim M., Faggiano A., de Herder W.W., Valk G.D. Incidence of gastroenteropancreatic neuroendocrine tumours: a systematic review of the literature. Endocr. Relat. Cancer. 2014; 21 (3): 153–163. DOI: 10.1007/s12022-012-9221-z.
8. Kloppel G., Rindi G., Perren A., Komminoth P., Klimstra D.S. The ENETS and AJCC/UICC TNM classifications of the neuroendocrine tumors of the gastrointestinal tract and the pancreas: a statement. Virch. Arch. 2010; 456 (6): 595–597. DOI: 10.1016/j.humpath.2007.09.010.
9. Niederle M.B., Hackl M., Kaserer K., Niederle B. Gastroenteropancreatic neuroendocrine tumours: the current incidence and staging based on the WHO and European Neuroendocrine Tumour Society classification: an analysis based on prospectively collected parameters. Endocr. Relat. Cancer. 2010; 17 (2): 909–918. DOI: 10.1677/ERC-10-0152.
10. McCall C.M., Shi C., Cornish T.C. Grading of welldifferentiated pancreatic neuroendocrine tumors is improved by the inclusion of both Ki67 proliferative index and mitotic rate. Am. J. Surg. Pathol. 2013; 37 (11): 1671–1677. DOI: 10.1097/PAS.0000000000000089.
11. Lioyd R.V., Osamura R.Y., Kloppel G., Rosai J. WHO classification of tumors of endocrine organs. 4 edn. Lyon: IARC Press, 2017. P. 23. DOI: 10.1210/jcem.77.5.8077321.
12. Rindi G., Kloppel G., Alhman H., Caplin M., Couvelard A., de Herder W.W. TNM staging of foregut neuroendocrine tumors: a consensus proposal induding a grading system. Virchows Arch. 2006; 449 (3): 395–401. DOI: 10.1159/000098006.
13. Rindi G., Falconi M., Klersy C. TNM staging of neoplasms of the endocrine pancreas: Staging Manual. Chicago: Springer, 2017. P. 407–419. DOI: 10.1093/jnci/djs208.
14. Bergsland E.K., Woltering E.A., Rindi G. Neuroendocrine tumors of the pancreas. In: American Joint Committee on Cancer (AJCC). 8 edn. FJCC Cancer Staging Manual. Chicago: Springer, 2017. P. 407–419. DOI: 10.1007/s12022-014-9347-2.
15. Klimstra D., Arnold R., Capella C. Neuroendocrine neoplasms of the pancreas. WHO Classification of Tumors of the Digestive System. Lyon, 2010. P. 322–326. DOI: 10.1001/archsurg.142.4.347.
16. Bushnell D.L., Baum R.P. Standard imaging techniques for NETs. Endocrinol. Metab. Clin. North. Am. 2011; 40 (1): 153–162. DOI: 10.1186/1477-7819-3-58.
17. Bosman F. WHO classification of tumors of the digestive system. Lyon: IARC Press, 2010. P. 23. DOI: 10.1007/s12022-014-9347-2.
18. Kubyshkin V.A., Kochatkov A.V., Konstantinova M.M., Krieger A.G. Neuroendocrine pancreatic neoplasia: terminology, classification and staging. Khirurgia. 2012; 6: 4–8. (In Russian)
19. Simonenko V.B., Dulin P.A., Makanin M.A. Nejroehndokrinnye opuholi [Neuroendocrine tumor]. Moscow: GEOTHAR-Media, 2010. 240 p. (In Russian)
20. Delektorskaya V.V. Neuroendocrine tumors of the digestive system: morphological and molecular features. Uspekhi molekulyarnoy onkologii. 2015; 2 (1): 52–60. (In Russian)
21. Pinsky S.B., Beloborodov V.A., Batoroev Yu.K., Dvornichenko V.V. Neuroendocrine pancreatic tumors. Sibirskij medicinskij zhurnal. 2013; 5: 12–17. (In Russian)
22. Egorov A.V., Musaev G.H., Kondrashin S.A., Gurevich L.E., Fomina E.V., Vasilyev I.A., Anisimova O.V., Guznov I.G., Mayorova E.M. Diagnostics and treatment in patients with neuroendocrine pancreatic tumors due to multiple endocrine neoplasia syndrome type 1. Annaly khirurgicheskoy gepatologii = Annals of HPB surgery. 2010; 15 (3): 25–30. (In Russian)
23. Kuzin N.M., Egorov A.V. Nejroehndokrinnye opuholi podzheludochnoj zhelezy [Neuroendocrine tumors of the pancreas]. Moscow: Medicina, 2010. 208 p. (In Russian)
24. Simonenko V.B., Dulin P.A., Makanin M.A. Possibilities of targeted therapy of neuroendocrine tumors. Klinicheskaya medicina. 2014; 8: 5–14. (In Russian)
25. Kim M.K. Endoscopic ultrasound in gastroenteropancreatic neuroendocrine tumors. Gut Liver. 2012; 6 (4): 405–410. DOI: 10.5009/gnl.2012.6.4.405.
26. Kokhanenko N.Yu., Lugovoy A.L., Danilov S.A., Shiryaev Yu.N., Gurtskaya L.Z. Peculiarities of pathogenesis, clinical course and diagnosis of acute cholecystitis in patients with decompensated cardiovascular disease. Pediatr. 2015; 6 (4): 62–68. (In Russian)
27. Kehplin M., Kvols L. Nejroehndokrinnye opuholi. Rukovodstvo dlya vrachej [Neuroendocrine tumor]. Prakticheskaya medicina, 2011. 224 p. (In Russian)
28. Chernousov A.F., Egorov A.V., Musaev G.H. Neuroendocrine pancreatic tumors: 30-year experience of the Burdenko clinic of faculty-based surgery. Khirurgia. 2013; 7: 13–19. (In Russian)
29. Halperin D.M., Kulke M.H. Management of pancreatic neuroendocrine tumors. Gastroenterol. Clin. North. Am. 2012; 41 (1): 119–131. DOI: 10.1146/annurev-med-061813-012908.
30. Boyko N., Pavlovsky M.P., Kemin R.V. Apudomy podzheludochnoy zhelezy. Sovremennyye podkhody k metodam diagnostiki i khirurgicheskogo lecheniya bol'nykh. Sovremennyye aspekty khirurgicheskoy endokrinologii [Pancreatic apudomas. Modern aspects of surgical endocrinology]. Kharkov, 2011. P. 51–55. (In Russian)
31. Ojeaburu J.V., Ito T., Crafa P. Mechanism of acid hypersecretion postcurative gastrinoma resection. Dig. Dis. Sci. 2011; 56 (4): 139–154. DOI: 10.1007/s10620-010-1234-1.
32. Marchevsky A.M., Gupta R., Balzer B. Diagnosis of metastatic neoplasms: a clinicopathologic and morphologic approach. Arch. Pathol. Lab. Med. 2010; 134 (2): 194–206. DOI: 10.1043/1543-2165-134.2.194.
33. Leteurtre E. Pathologic diagnostic for a primary of metastatic neuroendocrine tumor. Ann. Pathol. 2011; 31 (5 Suppl): 79–80. DOI: 10.1007/s00428-010-0924-6.
34. Cives M., Strosberg J. An update on gastroenteropancreatic neuroendocrine tumors. Oncology (Williston Park). 2014; 28 (9): 27–35. DOI: 10.1159/000049159.
35. De Dosso S., Grande E., Barriuso J. The targeted therapy revolution in neuroendocrine tumors: in search of biomarkers for patient selection and response evaluation. Cancer Metastasis Rev. 2013; 32 (3–4): 465–477. DOI: 10.1046/j.1365-2362.2000.00700.x.
36. Kokhanenko N.Yu., Artemieva N.N., Cheremisin V.M., Shiryaev Yu.N., Antonov N.N., Koryakina T.V., Bernstein M.A. The difficulties of differential diagnosis of nonfunctioning neuroendocrine tumors and exocrine cancer of the pancreas. Annaly khirurgicheskoy gepatologii = Annals of HPB surgery. 2010; 15 (3): 31–38. (In Russian)
37. Maistrenko N.A., Romashchenko L.N., Lisanyuk M.V. Sovremennyye aspekty diagnostiki i lecheniya neyroendokrinnykh opukholey podzheludochnoy zhelezy [Modern aspects of diagnosis and treatment of neuroendocrine pancreatic tumors. Modern aspects of surgical endocrinology]. Kharkiv, 2011. P. 262–265. (In Russian)
38. Fendrich V., Bartsch D.K. Surgical treatment of gastrointestinal neuroendocrine tumors. Langenbecs Arch. Surg. 2011; 396 (3): 299–311. DOI: 10.1097/01.sla.0000246951.21252.60.
39. Frilling A., Modlin I.M., Kidd M., Russell C., Breitenstein S., Salem R. Recommendations for management of patients with neuroendocrine liver metastases. Lancet Oncol. 2014; 15 (1): 8–21. DOI: 10.1002/cncr.28760.
40. Öberg K., Knigge U., Kwekkeboom D. Neuroendocrine gastroentero-pancreatic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 2012; 23 (Suppl 7): 124–130. DOI: 10.1093/annonc/mds295.
41. Mayo S.C., Herman J.M., Cosgrove D. Emerging approaches in the management of patients with neuroendocrine liver metastasis: Role of liver-directed and systemic therapies. J. Am. Coll. Surg. 2013; 216 (1): 123–134. DOI: 10.1016/j.jamcollsurg.2012.08.027.
42. Zhao Y.P., Zhan H.X., Zhang T.P. Surgical management of patients with insulinomas: result of 292 cases in a single institution. J. Surg. Oncol. 2011; 103 (2): 169–174. DOI: 10.1097/PAS.0b013e3181ac675b.
43. Kokhanenko N.Yu., Pavelets K.V., Radionov Y.V., Shiryaev Yu.N., Borisova N.Yu. Study of life quality in patients after pylorussparing gastropancreatoduodenectomy and pancreato - duodenectomy in different terms after surgery. Pediatr. 2015; 6 (3): 48–51. (In Russian)
44. Soglasitel'nyye rekomendatsii ENETS (Yevropeyskoye obshchestvo po neyroendokrinnym opukholyam) po vedeniyu bol'nykh s neyroendokrinnymi opukholyami zheludochno-kishechnogo trakta: funktsioniruyushchiye neyroendokrinnyye opukholi podzheludochnoy zhelezy [ENETS conciliatory recommendations (European society for neuroendocrine tumors) for the management of patients with neuroendocrine tumors of the gastrointestinal tract: functioning neuroendocrine tumors of the pancreas]. Jensen R.T., Cadiot G.A., Brandi M.L., Herder W.W., Kaltsas G.B., Komminoth P.R., Scoazec J.Y., Salazar R.R., Sauvanet A.S., Kianmanesh R.D. the participants in the conciliation conference in Barcelona. Neuroendocrinology. 2012; 95: 98–119. Translation: D.G. Bel'tsevich. (In Russian)
45. Oriol N.F., Markovich A.A. Targeted therapy for neuroendocrine tumors of the gastrointestinal tract and pancreas. Sovremennaya onkologiya. 2010; 3: 57–61. (In Russian)
46. Hobday T.J., Qin R., Moore M., Reidy-Lagunes D.L., Strosberg J.R., Kindler H.L. Multicenter phase II trial of temsirolimus and bevacizumab in pancreatic neuroendocrine tumor: Results of a planned interim efficacy analysis. J. Clin. Oncol. 2012; 33 (14): 1551–1556. DOI: 10.1200/JCO.2014.56.2082.
47. Markovich A.A., Eagle N.F., Polozkova S.A., Gorbunova V.A. Neuroendocrine tumors of the gastrointestinal tract and pancreas. Sovremennaya onkologiya. 2011; 3: 37–44. (In Russian)
Review
For citations:
Kokhanenko N.Yu., Morgoshiya T.Sh. Neuroendocrine tumors of the pancreas: etio-pathogenesis, diagnosis, current treatment. Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery. 2018;23(2):100-110. (In Russ.) https://doi.org/10.16931/1995-5464.20182100-110
Views:
2325
Email this article 